Oseltamivir 60 mg per 5 mL Oral Suspension
RxNorm 314157
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 314157 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: oseltamivir 60 mg per 5 mL Oral Suspension.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCD
Semantic Clinical Drug (SCD):
Oseltamivir 12 mg/ML Oral Suspension
(Atom ID: 12339713)
PT
Designated preferred name (PT):
Oseltamivir (as oseltamivir phosphate) 12 mg/mL oral suspension
(Atom ID: 12756430)
SY
Synonym (SY):
Oseltamivir 60 mg per 5 mL Oral Suspension
(Atom ID: 3804312)
FN
Full form of descriptor (FN):
Product containing precisely oseltamivir (as oseltamivir phosphate) 12 mg/1 mL conventional release oral suspension (clinical drug)
(Atom ID: 12757402)
Patient Education
Oseltamivir
Oseltamivir is used to treat some types of influenza infection ('flu') in adults, children, and infants (older than 2 weeks of age) who have had symptoms of the flu for no longer than 2 days. This medication is also used to prevent some types of flu in adults and children (older than 1 year of age) when they have spent time with someone who has the flu or when there is a flu outbreak. Oseltamivir is in a class of medications called neuraminidase inhibitors. It works by stopping the spread of the flu virus in the body. Oseltamivir helps shorten the time that flu symptoms such as a stuffy or runny nose, sore throat, cough, muscle or joint aches, tiredness, headache, fever, and chills last. Oseltamivir will not prevent bacterial infections, which may occur as a complication of the flu.
[Learn More]
* Please review the disclaimer below.